| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1060 | 2019 |
| Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) T Poynard, P Lebray, P Ingiliz, A Varaut, B Varsat, Y Ngo, P Norha, ... BMC gastroenterology 10, 1-13, 2010 | 248 | 2010 |
| HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe P Ingiliz, TC Martin, A Rodger, HJ Stellbrink, S Mauss, C Boesecke, ... Journal of hepatology 66 (2), 282-287, 2017 | 207 | 2017 |
| Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus‐1 mono‐infected patients on antiretroviral therapy P Ingiliz, MA Valantin, C Duvivier, F Medja, S Dominguez, F Charlotte, ... Hepatology 49 (2), 436-442, 2009 | 168 | 2009 |
| Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy C Yurdaydin, Z Abbas, M Buti, M Cornberg, R Esteban, O Etzion, EJ Gane, ... Journal of Hepatology 70 (5), 1008-1015, 2019 | 119 | 2019 |
| Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers T Poynard, P Ingiliz, L Elkrief, M Munteanu, P Lebray, R Morra, ... PloS one 3 (12), e3857, 2008 | 119 | 2008 |
| Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: the Hepatitis Delta International Network (HDIN) A Wranke, LM Pinheiro Borzacov, R Parana, C Lobato, S Hamid, ... Liver International 38 (5), 842-850, 2018 | 100 | 2018 |
| An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load Y Ngo, Y Benhamou, V Thibault, P Ingiliz, M Munteanu, P Lebray, ... PLoS One 3 (7), e2573, 2008 | 98 | 2008 |
| Sofosbuvir and ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus (HCV) infection in HCV-monoinfected and HIV-HCV–coinfected individuals: Results from the … P Ingiliz, S Christensen, T Kimhofer, D Hueppe, T Lutz, K Schewe, ... Clinical infectious diseases 63 (10), 1320-1324, 2016 | 90 | 2016 |
| Biomarkers of liver fibrosis T Poynard, R Morra, P Ingiliz, F Imbert‐Bismut, D Thabut, D Messous, ... Advances in Clinical Chemistry 46, 131-160, 2008 | 90 | 2008 |
| Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases F Nascimbeni, P Lebray, L Fedchuk, CP Oliveira, MR Alvares-da-Silva, ... Clinical Gastroenterology and Hepatology 13 (4), 763-771. e6, 2015 | 84 | 2015 |
| Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial JK Rockstroh, S Bhagani, RH Hyland, C Yun, H Dvory-Sobol, W Zheng, ... The lancet Gastroenterology & hepatology 2 (5), 347-353, 2017 | 83 | 2017 |
| Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia M Lemoine, Y Shimakawa, R Njie, HF Njai, S Nayagam, M Khalil, ... Alimentary pharmacology & therapeutics 39 (2), 188-196, 2014 | 79 | 2014 |
| Efficacy of direct-acting antivirals for chronic hepatitis C virus infection in people who inject drugs or receive opioid substitution therapy: a systematic review and meta … C Graf, MM Mücke, G Dultz, KH Peiffer, A Kubesch, P Ingiliz, S Zeuzem, ... Clinical Infectious Diseases 70 (11), 2355-2365, 2020 | 74 | 2020 |
| Diagnostic accuracy of noninvasive markers of steatosis, NASH, and liver fibrosis in HIV-monoinfected individuals at risk of nonalcoholic fatty liver disease (NAFLD): results … M Lemoine, L Assoumou, S De Wit, PM Girard, MA Valantin, C Katlama, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (4), e86-e94, 2019 | 73 | 2019 |
| Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa Y Shimakawa, R Njie, G Ndow, M Vray, PS Mbaye, P Bonnard, R Sombié, ... Journal of hepatology 69 (4), 776-784, 2018 | 72 | 2018 |
| Assessment of liver fibrosis: noninvasive means T Poynard, R Morra, P Ingiliz, F Imbert-Bismut, D Thabut, D Messous, ... Saudi Journal of Gastroenterology 14 (4), 163-173, 2008 | 68 | 2008 |
| Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates, compared with … P Ingiliz, MH Wehmeyer, C Boesecke, J Schulze Zur Wiesch, K Schewe, ... Clinical Infectious Diseases 71 (5), 1248-1254, 2020 | 67 | 2020 |
| An effective interferon‐gamma‐mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in … P Kokordelis, B Krämer, C Körner, C Boesecke, E Voigt, P Ingiliz, ... Hepatology 59 (3), 814-827, 2014 | 64 | 2014 |
| High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection J Von Felden, J Vermehren, P Ingiliz, S Mauss, T Lutz, KG Simon, ... Alimentary pharmacology & therapeutics 47 (9), 1288-1295, 2018 | 59 | 2018 |
